Novo Announces U.S. Launch of NovoPen Echo® Insulin Injection Device

This press release is an announcement submitted by Novo Nordisk, and was not written by Diabetes Health.

The new NovoPen Echo

Jan 24, 2014

Plainsboro, N.J.--Novo Nordisk has announced the U.S. launch of its NovoPen Echo® insulin delivery device. It is the first and only pen device available in this country with half-unit dosing and a memory function that records the dose and time passed since the last injection.

"We believe this pen can help patients fine-tune their dosing while offering added reassurance they are managing their diabetes appropriately," said George McAvoy, vice president, NovoLog brand team at Novo Nordisk.

Because half-unit dose increments allow for finer adjustments, the device can be particularly useful to children, who often require more closely adjusted dosages. In addition, 12 removable skins are available for a customized look, including kid-friendly designs.

Jeff Hitchcock, founder of Children with Diabetes, said the device "is a welcome addition to the tools children with diabetes and their caregivers have available, especially when kids are away from home."

The new pen is available to patients for use with NovoLog® PenFill® cartridges. Novo Nordisk has already launched NovoPen Echo® in Europe, Canada, and Israel.

For more information on Novo Nordisk products, visit www.novonordisk-us.com.

 

Click Here To View Or Post Comments

Categories: Insulin Delivery Device, Insulin Pen, Novo Nordisk, NovoPen Echo


Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • What's on the Horizon with Diabetes Research and Therapy
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Latest
Popular
Top Rated
Print | Email | Share | Comments (0)

You May Also Be Interested In...


Comments


Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...


Username: Password:
Comment:
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.